Expert Insights
Channels
Themes
Active ETFs
ETF Investing
Alternatives
ETF Strategist
Artificial Intelligence
ETF Yield
Beyond Basic Beta
Financial Literacy
China Insights
Fixed Income
Climate Insights
Free Cash Flow
Core Strategies
Innovative ETFs
Crypto
Institutional Income Strategies
Disruptive Technology
Leveraged & Inverse
Energy Infrastructure
Modern Alpha
ETF Building Blocks
Portfolio Construction
ETF Education
Tax Efficient Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Commodities
Currency
Gold/Silver/Critical Minerals
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Exchange
Events
Exchange
Alternatives Symposium
Fixed Income Symposium
Equity Symposium
Cryptocurrency Symposium
Market Outlook Symposium
Company
About VettaFi
Get VettaFi’ed
Search Results: pharma (1563)
Featured
Fun With Pharma ETFs
By
Todd Shriber
January 21, 2014
Featured
The One ETF Really Benefiting From the Intercept Pharma News
By
Todd Shriber
January 9, 2014
Featured
Pharma ETFs Could Flatline on Obamacare Bust
By
Max Chen
November 20, 2013
Featured
Help From the Hill Could Add to Pharma ETFs’ Gains
By
Tom Lydon
November 16, 2013
Featured
Sturdy Pharma ETF Could Pullback
By
Todd Shriber
October 22, 2013
Featured
Buyers Stepped Into This Pharma ETF This Week
By
Todd Shriber
October 11, 2013
Featured
Pharmaceutical ETFs: A Defensive Play in 2012?
By
Tom Lydon
April 25, 2012
Featured
Utilities, Consumer and Pharma ETFs Lead 2011
By
Tom Lydon
December 19, 2011
Featured
ETF Spotlight: Pharmaceuticals
By
Tom Lydon
October 13, 2011
Featured
Healthcare, Pharma ETFs Hit by Pfizer Decline
By
John Spence
May 3, 2011
Featured
Pfizer to Weigh on Pharma, Healthcare ETFs
By
John Spence
May 3, 2011
Featured
Will Pfizer Help or Hurt Rallying Pharma ETFs?
By
John Spence
May 2, 2011
Featured
Pfizer Earnings to Dominate Healthcare, Pharma ETFs
By
John Spence
May 2, 2011
Featured
Pharma, Healthcare ETFs in Focus on M&A Talk, Earnings
By
John Spence
April 18, 2011
Featured
Pharmaceutical ETFs Look to the Future
By
Tom Lydon
January 29, 2011
Featured
Pharmaceutical ETFs: Drug Companies Roar Back
By
Tom Lydon
November 16, 2010
Featured
Pharma ETFs Find New Avenues of Growth
By
Tom Lydon
October 8, 2010
Featured
ETFs for a Changing Pharma Landscape
By
Tom Lydon
August 5, 2010
Previous
1
…
4
5
6
7
8
…
87
Next
X
